Trastuzumab Active Not Recruiting Phase 2 Trials for Her-2 Positive Gastric Cancer / Metastatic or Recurrent Gastric Adenocarcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01396707Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC)